Objective. Inflamed tissue is characterized by low availability of oxygen and nutrients. Yet CD4+ T helper lymphocytes persist over time in such tissue and probably contribute to the chronicity of inflammation. This study was undertaken to analyze the metabolic adaptation of these cells to the inflamed environment.
INTRODUCTION
CD4+ T lymphocytes are considered a driving force and relevant therapeutic target in chronic inflammatory rheumatic diseases. In the inflamed synovial tissue of patients, CD4+ T lymphocytes persist despite low levels of oxygen and nutrients, and they are refractory to conventional immunosuppressive therapies (1, 2) . With respect to nutrients qualifying as a metabolic energy source, there is little glucose (3) and glutamine (4) in inflamed tissue, while fatty acids are readily available (5, 6) . Herein, we describe the metabolic adaptation of CD4+ T lymphocytes to this inflamed environment.
Among the CD4+ T lymphocytes present in inflamed tissues, CD4+ T cells expressing programmed death 1 (PD-1) protein (7) are a subpopulation of potential relevance for pathogenesis (8) . In this study, we show that PD-1+ Th1 cells isolated from the synovial | 1757 fluid of patients with juvenile idiopathic arthritis (JIA) are dependent on fatty acid oxidation for survival. Their survival is blocked by the carnitine palmitoyltransferase 1 inhibitor etomoxir (9) , which inhibits the transport of fatty acids from the cytoplasm into the mitochondria. We show that CD4+ PD-1+ T cells in inflamed synovia express the E-box-binding transcription factor TWIST1, a hallmark of T lymphocytes persisting in chronically inflamed human tissue (2) .
Twist1 expression is selective for repeatedly activated murine Th1 cells, as compared to other types of T helper cells and Th1 cells activated only once. Twist1 expression by murine Th1 cells has been shown to dampen immunopathology in an autoregulatory, cell-intrinsic manner (2) . At the same time, Twist1 supports the persistence of repeatedly activated Th1 cells by inducing expression of microRNA-148a (miR-148a), which in turn regulates expression of the proapoptotic protein Bim (10) . We previously demonstrated that selective depletion of Twist1-expressing Th1 cells through blockade of miR-148a, a Twist1-induced miRNA, in vivo with antagomirs ameliorates inflammation, identifying Twist1-expressing T helper cells as those driving inflammation (11) . Conditional inactivation of Twist1 in repeatedly activated Th1 lymphocytes relieves their dependency on fatty acid oxidation and allows them to survive alternatively on glycolysis, demonstrating that Twist1 forces T helper cells into fatty acid oxidation, and thus regulates their proinflammatory activity (12, 13) . Twist1 thus qualifies as an essential regulator of the metabolism of T helper lymphocytes in chronic inflammation, inhibiting glycolysis, and thus limiting immunopathology, while at the same time stimulating fatty acid oxidation, allowing the cells to persist in and contribute to the chronification of inflammation.
MATERIALS AND METHODS
Mice. C57BL/6J mice were purchased from Charles River. OT-II × Twist1 fl/fl × CD4Cre +/− and OT-II × Twist1 wt/wt × CD4Cre +/− , Twist1 fl/fl × CD4Cre +/− , and Twist1 wt/wt × CD4Cre +/− mice were bred in the Deutsches Rheuma-Forschungszentrum animal facility under specific pathogen-free conditions in individually ventilated cages. Mice were handled in accordance with good animal practice as defined by the German animal welfare bodies, and killed by cervical dislocation. All experiments were approved by the State Office for Health and Social Affairs (Berlin, Germany).
Human patient samples. Peripheral blood and synovial fluid samples were collected at the Department of Pediatrics, Pediatric Rheumatology Section of Charité-Universitätsmedizin Berlin as approved by the ethics committee of Charité-Universitätsmedizin Berlin (approval no. EA2/069/15).
Human T cell phenotyping and cultivation.
Mononuclear cells from peripheral blood were isolated by Ficoll density-gradient centrifugation. Synovial fluid cells were depleted of CD14+ granulocytes by magnetic cell sorting using CD14 microbeads (Miltenyi Biotec). CD4+ T helper lymphocytes were isolated using CD4 microbeads (Miltenyi Biotec). For analysis of cytokine expression, synovial CD4+ T cells were stimulated with phorbol 12-myristate 13-acetate (PMA) (10 ng/ml) and ionomycin (1 μg/ml) (both from Sigma-Aldrich) for a total of 5-6 hours in medium. After 1 hour, 5 μg/ml brefeldin A (BioLegend) was added to block the secretion of cytokines. Cells were fixed with Cytofix/Cytoperm (BD Biosciences) for 20 minutes at 4°C and stained intracellularly with anti-interferonγ (anti-IFNγ) (4SB3; BioLegend), antiinterleukin-17a (anti-IL-17a) (BL168; BioLegend), anti-tumor necrosis factor (anti-TNF) (cA2; Miltenyi Biotec), anti-IL-2 (MQ1-17H12; BioLegend), anti-IL-10 (JES3-9D7; Miltenyi Biotec), anti-IL-4 (8D48; BioLegend), and anti-IL-21 (7H20-I19-M3; BioLegend) according to published guidelines (14) . For intracellular T-bet staining (4B10; BioLegend), cells were additionally permeabilized with 0.01% Triton X-100 for 10 minutes on ice. PD-1+ and PD-1− CD3+CD4+CD14−CD45RO+ T lymphocytes were sorted by fluorescence-activated cell sorting (FACS) using a FACSAria cell sorter (BD Biosciences) and plated in RPMI medium containing human AB serum (Sigma), 100 units/ml penicillin, and 100 μg/ml streptomycin (Life Technologies). Etomoxir was added to the final concentrations as indicated. The numbers of viable CD4+ T cells were monitored over time by flow cytometry, using DAPI to exclude dead cells.
In vitro cultivation and differentiation of murine T helper cells.
Murine CD4+CD62L+ (naive) T helper cells were isolated as previously described (15) and cultured at a concentration of 2.5 × 10 6 cells/5 ml in 6-well plates in RPMI medium supplemented with 10% fetal calf serum (Merck), 300 μg/ml glutamine (Invitrogen), 100 units/ml penicillin, 100 μg/ml streptomycin (Life Technologies), and 50 μM β-mercaptoethanol (Sigma-Aldrich) at 37°C in 5% CO 2 and 4.2% oxygen. The T helper cells were stimulated polyclonally with plate-bound anti-CD3 antibody (145-2C11; 3 μg/ml) and soluble anti-CD28 antibody (37.51; 1.5 μg/ml). For Th1 polarization, 5 ng/ml recombinant IL-12, 10 ng/ml recombinant IL-2, and 10 μg/ml anti-IL-4 antibody (11B11) was added. To induce Th17 polarization, 10 μg/ml anti-IFNγ (AN18.17.24), 10 μg/ml anti-IL-4 (11B11), 20 ng/ml recombinant IL-6, 20 ng/ml recombinant IL-23, and 1 ng/ml recombinant transforming growth factor β (all from R&D Systems) were added. After 48 hours of stimulation, the cells were removed from the antibody-coated culture dishes and cultured for an additional 3-4 days. T cell receptor-transgenic OT-II lymphocytes were activated with 1 μg/ml of ovalbumin 327-339 peptide in the presence of irradiated (30 Gy) CD90-depleted splenocytes from C57BL/6 mice. For repeated activation, viable T helper cells were isolated using Ficoll density-gradient centrifugation and stimulated again under the original conditions. Quantitative RNA expression analysis. Total RNA was isolated using an RNeasy kit (Qiagen) or a Direct-zol RNA kit (Zymo Research) according to the manufacturer's instructions. RNA concentration and quality were determined by NanoDrop spectrometry. RNA (200 ng to 1 μg) was reverse transcribed using a TaqMan Reverse Transcription kit (Ther-moFisher Scientific) according to the manufacturer's recommendations. Real-time quantitative polymerase chain reaction was used to quantify the messenger RNA of interest with the following primer sets (TIB Molbiol Berlin): for murine hypoxanthine guanine phosphoribosyltransferase (Hprt), forward 5′-TCCTCCTCAGACCGCTTTT-3′ and reverse 5′-CATAA CCTGGTTCATCATCGC-3′; for human HPRT, forward 5′-ACCC TTTCCAAATCCTCAGC-3′ and reverse 5′-GTTATGGCGACC CGCAG-3′; for murine Twist1, forward 5′-CGCACGCAGTCGC TGAACG-3′ and reverse 5′-GACGCGGACATGGACCAGG-3′; for human TWIST1, forward 5′-GGCACCCAGTCGCTGAACG-3′ and reverse 5′-GACGCGGACATGGACCAGG-3′; for murine Pdcd1, forward 5′-CGTCCCTCAGTCAAGAGGAG-3′ and reverse 5′-GTCCCTAGAAGTGCCCAACA-3′. Prior to Twist1 analysis, cultured cells were restimulated with PMA (10 ng/ml) and ionomycin (1 μg/ml) for 5 hours.
Glucose uptake assay. Murine naive CD4+ T helper cells were stimulated with 3 μg/ml of plate-bound anti-CD3 and 1.5 μg/ ml of soluble anti-CD28 antibodies at 3 × 10 5 cells per well under Th1-inducing conditions for 5 hours. Medium was then aspirated, and 100 μl of glucose-free medium with 1.5 μg/ml of soluble anti-CD28 antibody was added to the cells. Following incubation for 60 minutes, 100 μl of glucose-free RPMI with 300 μM 2-([7nitro-2,1,3-benzoxadiazol-4-yl]amino)-2 deoxyglucose (2-NBDG) was added to the well, to reach a final concentration of 150 μM 2-NBDG. Cultures with no 2-NBDG added and cultures with 150 μM 2-NBDG and 30 μM cytochalasin B were used as controls. Cells were incubated for 30 minutes at 37°C. After incubation, cells were washed twice in cold phosphate buffered saline (PBS) and maintained at 4°C. Uptake of 2-NBDG was determined by flow cytometry using a MACSQuant analyzer. Dead cells were excluded by propidium iodide staining.
Determination of lactate production and oxygen consumption. Glycolysis, as determined by extracellular acidification, and oxidative phosphorylation, as determined by oxygen consumption, were measured using a Seahorse XP analyzer (Agilent). Prior to the assay, T lymphocytes were starved in glucosefree RPMI assay medium and equilibrated in 5% CO 2 at 37°C, under normoxic conditions. T cell survival assay. CD4+ T helper cells were seeded in a 96-well plate coated with 3 μg/ml anti-CD3 antibodies and 1.5 μg/ml soluble anti-CD28 antibodies under Th1-or Th17polarizing conditions. The inhibitors 2-deoxyd-glucose (2-DG; 2 mM), 6-diazo-5-oxol-norleucine (50 μM), oligomycin (2 μM), or etomoxir (150 μM) were added. Dead cells were excluded by staining with 100 ng/ml propidium iodide or 100 ng/ml DAPI. Numbers of viable cells were determined by flow cytometry using a MACSQuant analyzer.
Lipid peroxidation. BODIPY 581/591 C11 was added to CD4+ T lymphocytes in a 96-well plate at a final concentration of 3 μM in RPMI without serum and 2-mercaptoethanol. Cells were incubated for 40 minutes at 37°C and then washed with PBS/bovine serum albumin. Viable cells were quantified using a MACSQuant analyzer, and dead cells were excluded by DAPI staining.
RESULTS

Survival of PD-1+CD4+ T helper lymphocytes in
inflamed synovia via fatty acid oxidation. CD4+ T helper lymphocytes were isolated from the synovial fluid of patients with JIA. More than 70% of the CD3+CD4+ cells were CD45RO+CD45RA− ( Figure 1A) . Upon stimulation with PMA and ionomycin ex vivo, ~50% of them expressed IFNγ, 70% expressed TNF, 50% expressed IL-2, and 10% expressed IL-10. IL-4, IL-17, and IL-21 were each expressed by <10% of the cells ( Figure 1B) . Consistent with the cytokine expression pattern, almost all JIA synovial T helper cells expressed the T-box-binding transcription factor T-bet, identifying them as bona fide Th1 cells ( Figure 1C) . A significantly higher proportion of synovial T helper cells than peripheral blood T helper cells expressed PD-1 ( Figures 1D and E) .
PD-1+ and PD-1− synovial T helper cells were separated by FACS (Figure 2A and Supplementary Figure 1 , available on the Arthritis & Rheumatology web site at http://onlin elibr ary.wiley.com/ doi/10.1002/art.40939/ abstract), and their dependency on fatty acid oxidation was analyzed. CD4+CD45RO+ T cells isolated from the blood of healthy donors did not survive when cultured in vitro under hypoxic conditions (4.2% O 2 ), with >90% of them dying within 2 days. Of the PD-1− T helper cells isolated from synovial fluid, a mean ± SEM of 24.6 ± 2.29% survived until day 2 of culture and 19 ± 1.31% survived until day 4. Their survival was not affected by the addition of etomoxir, an inhibitor of fatty acid oxidation. In the presence of etomoxir, 20% of the cells survived until day 2 and 15.6 ± 4.5% survived until day 4 ( Figure 2B ). Of the PD-1+ synovial T helper cells, 39.85 ± 7.35% survived until day 2, and these surviving cells expanded again to 60 ± 7.08% of the original number on day 4. Survival and expansion of these cells was entirely dependent on fatty acid oxidation, since they could be blocked with etomoxir, reducing cell numbers to a mean ± SEM of 3.4 ± 2.85% on day 4 ( Figure 2B) .
We have previously shown that the E-box-binding transcription factor TWIST1 is a hallmark of T helper lymphocytes isolated from the inflamed joints of patients with rheumatic diseases (2) . In this study, we found that PD-1+ synovial T cells isolated from the inflamed joints of patients with JIA expressed significantly higher levels of TWIST1 than PD-1− T helper cells isolated from the same synovia ( Figure 2C ).
Upon repeated activation, murine Th1 cells shift from glycolysis to fatty acid oxidation.
To investigate the role of Twist1 in the regulation of the metabolism of T helper lymphocytes, we used a murine model of repeatedly activated Th1 lymphocytes, which was previously used as a model to study transcriptional adaptations of chronic activation and in which we had previously demonstrated up-regulated Twist1 expression (2). Naive CD4+CD62L+ T cells were stimulated with anti-CD3 and anti-CD28 antibodies 4 times at 6-day inter- vals. We then compared the capacity of these cells to take up glucose and perform glycolysis, the latter reflected by the production of lactate, as outlined in Figure 3A . Uptake of the fluorescent glucose analog 2-NBDG was monitored by flow cytometry. Repeatedly activated mouse Th1 cells took up 2.3-fold less 2-NBDG than mouse Th1 cells that were activated one time ( Figure 3B ). Repeatedly activated murine Th1 cells were also less efficient in glycolysis, compared to Th1 cells activated once. Murine Th1 cells activated once produced 1.4-fold more lac- Figure 3 . Repeatedly stimulated (stim) murine Th1 cells switch their metabolism from glycolysis to fatty acid oxidation. A, Experimental design. Naive CD4+CD62L+ T cells isolated from C57BL/6 mice were stimulated once or stimulated 2 additional times at 6-day intervals with anti-CD3/ anti-CD28 antibodies under Th1-differentiating conditions. Cells were analyzed for energy metabolism. OXPHOS = oxidative phosphorylation. B, Glucose uptake in murine Th1 cells stimulated once and repeatedly stimulated murine Th1 cells, measured by flow cytometry using the fluorescent glucose analog 2-([7-nitro-2,1,3-benzoxadiazol-4-yl]amino)-2 deoxyglucose (2-NBDG). Th1 cells were restimulated for 6 hours with anti-CD3 and anti-CD28 antibodies prior to analysis. Cytochalasin B (CytB) was used to determine background fluorescence. Bars show the mean ± SEM. Results are representative of 3 independent experiments. *** = P < 0.0006 by Mann-Whitney 2-tailed test. C, Glycolytic activity, measured by extracellular acidification rate (ECAR), in murine Th1 cells stimulated once and repeatedly stimulated murine Th1 cells before and after restimulation with phorbol 12-myristate 13-acetate (PMA) and ionomycin (iono). Values are the mean ± SEM (n = 4 samples per group). *** = P < 0.0001 at 14 minutes, P = 0.0027 at 30 minutes, and P = 0.0027 at 50 minutes after glucose addition, by 2-tailed t-test. D, Frequency of viable murine CD4+ T cells stimulated once and murine CD4+ T cells stimulated repeatedly after restimulation with anti-CD3/anti-CD28 antibodies in the presence of the glycolysis inhibitor 2-deoxyd-glucose (2-DG; 2 mM) for 72 hours, relative to cells cultivated without inhibitor tate than repeatedly activated murine Th1 cells in the presence of glucose, before and after stimulation with PMA and ionomycin ( Figure 3C ). Lactate production remained significantly lower in repeatedly activated murine Th1 cells thereafter.
Of the Th1 cells that had been activated once, inhibition of glycolysis with 2-DG killed 85% within 72 hours after activation, suggesting that such Th1 cells were dependent on glycolysis.
In contrast, 50% of the repeatedly stimulated murine Th1 cells survived when glycolysis was inhibited by 2-DG ( Figure 3D ), demonstrating that repeatedly stimulated T helper cells have alternative metabolic options, i.e., fatty acid oxidation. Blocking fatty acid oxidation with etomoxir for up to 8 days after a third reactivation showed that repeatedly stimulated murine Th1 cells use and are dependent on fatty acid oxidation, in particular in the late phase of expansion, between days 3 and 5 ( Figure 3E ). This was not the case for murine Th1 cells during the first week after the first reactivation ( Figure 3F ), which survived and proliferated even in the presence of etomoxir. The metabolism of repeatedly restimulated murine Th1 cells thus corresponds to that of PD-1 high human T helper cells isolated from inflamed synovia, in that they are dependent on fatty acid oxidation.
Inhibition of glycolysis of Th1 lymphocytes by Twist1.
To analyze the role of Twist1 in regulating the metabolism of T helper cells functionally, we used mice with a conditional, cell type-specific knockout of Twist1 (CD4Cre × Twist1 fl/fl ) (10) (Supplementary Figure 2 , available on the Arthritis & Rheumatology web site at http://onlin elibr ary.wiley.com/doi/10.1002/art.40939/ abstract). Both the Twist1-deficient mouse Th1 cells that had been stimulated once and those that had been stimulated repeatedly showed an increased rate of glycolysis, as reflected by an increased production of lactate, when compared to their wild-type counterparts ( Figures 4A and B) , indicating that Twist1 inhibits glycolysis. Twist1 selectively regulated the glycolysis of Th1, but not of repeatedly stimulated Th17 cells ( Supplementary Figure 3 , Requirement of Twist1 for the survival of Th1 lymphocytes via fatty acid oxidation. Twist1 is indispensable for the survival of repeatedly stimulated Th1 cells via fatty acid oxidation. When glycolysis and glutaminolysis were blocked by 2-DG and 6-diazo-5-oxo-L-norleucine, respectively, Twist1deficient mouse T helper cells did not survive ( Figure 4C ). In this situation, when fatty acid oxidation is the only metabolic pathway available, the competence to survive on this pathway depends on Twist1.
Twist1 protects Th1 cells against reactive oxygen species (ROS). Consistent with fatty acid oxidation being the major energy source for repeatedly stimulated murine Th1 cells, these cells show a higher degree of oxidative phosphorylation than murine Th1 cells stimulated once, both in the rest-ing phase and after reactivation ex vivo ( Figure 5A ). Oxidative phosphor ylation is associated with the generation of ROS. ROS promote peroxidation of lipids in cell membranes, an effect that has been suggested to be involved in the pathogenesis of rheumatoid arthritis (16, 17) . In T helper lymphocytes, lipid peroxides of the membrane, as detected by BODIPY C11 staining, were more abundant in T helper cells that had been stimulated 3 times, 8 days after reactivation, compared to T helper cells that had been stimulated once ( Figure 5B ). Compared to Twist1-deficient mouse Th1 cells, Twist1-sufficient (wild-type) mouse Th1 cells, both those stimulated once and those stimulated repeatedly, showed significantly reduced lipid peroxidation (P = 0.002 for cells stimulated once and P = 0.0323 for cells stimulated repeatedly) ( Figure 5B ). These data suggest that in addition to promoting oxidative phosphorylation through fatty acid oxidation, Twist1 protects murine Th1 cells against harmful lipid peroxides, presumably by enhancing lipid peroxide scavenging. Figure 5 . Repeatedly stimulated Th1 cells have increased oxidative phosphorylation. A, Oxidative phosphorylation (OXPHOS), measured by oxygen consumption rate (OCR) in Th1 cells stimulated once and Th1 cells stimulated repeatedly, before and after addition of glucose and restimulation with 12-myristate 13-acetate (PMA) and ionomycin (iono). Values are the mean ± SEM. *** = P < 0.0001 at 15 minutes; P = 0.0009 at 28 minutes; and P = 0.64 at 52 minutes, by paired t-test. Results are representative of 3 independent experiments. B, Levels of lipid peroxides in wild-type (WT) and Twist1-deficient (knockout [KO]) mouse Th1 cells stimulated once or stimulated repeatedly. Levels were determined by BODIPY 581/591 C11 (2 μM) staining 7 days after the last reactivation with anti-CD3/anti-CD28 antibodies. Bars show the mean ± SEM. * = P = 0.0323; ** = P = 0.002, by paired 2-tailed t-test. MFI = mean fluorescence intensity. 
